Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease

Autor: Miriam Sjåstad Langseth, Trine Baur Opstad, Ragnhild Helseth, A.A. Pettersen, Vibeke Bratseth, Svein Solheim, Ingebjørg Seljeflot, Harald Arnesen
Rok vydání: 2018
Předmět:
Zdroj: European Journal of Preventive Cardiology. 25:762-769
ISSN: 2047-4881
2047-4873
DOI: 10.1177/2047487318760618
Popis: Background Neutrophil extracellular traps, comprising chromatin and granule proteins, have been implicated in atherothrombosis. Design and methods We investigated whether the circulating neutrophil extracellular traps markers, double-stranded DNA and myeloperoxidase-DNA were associated with clinical outcome and hypercoagulability in patients with stable coronary artery disease. Patients with angiographically verified stable coronary artery disease ( n = 1001) were included. Follow-up was 2 years, recording 106 clinical endpoints (unstable angina, non-haemorrhagic stroke, myocardial infarction or death). Serum collected at baseline was used to determine double-stranded DNA and myeloperoxidase-DNA levels. Results The neutrophil extracellular traps markers were weakly intercorrelated ( r = 0.103, P = 0.001). Patients with the highest quartile of double-stranded DNA had weakly but significantly elevated hypercoagulability markers (prothrombin fragment 1+2, D-dimer, free and total tissue factor pathway inhibitor ( P Conclusions Double-stranded DNA levels were significantly related to adverse clinical outcome after 2 years, but only weakly associated with hypercoagulability. These observations suggest that the detrimental effects of neutrophil extracellular traps in coronary artery disease might extend beyond those related to hypercoagulability.
Databáze: OpenAIRE